Skip to main navigation Skip to search Skip to main content

Mitigating Teclistamab Toxicity: Prophylactic Tocilizumab and Timing of Immunoglobulin Replacement Therapy in a Nationwide Cohort

  • Astrid Hundebøll Torpe
  • , Jonathan Thorsen
  • , Gustav Mathiasen
  • , Katrine Fladeland Iversen
  • , Sarah Farmer
  • , Thomas Lund
  • , Charlotte Toftmann Hansen
  • , Lene Kongsgaard Nielsen
  • , Nicolai Grønne Dahlager Jørgensen
  • , Maja Ølholm Vase
  • , Elena Manuela Teodorescu
  • , Morten Salomo
  • , Christina Wennerström
  • , Tobias S. Slørdahl
  • , Agoston Gyula Szabo*
  • *Corresponding author for this work

Research output: Contribution to journal › Letter › peer-review

8 Downloads (Pure)
Original languageEnglish
JournalAmerican Journal of Hematology
Volume101
Issue number8
Pages (from-to)2081-2085
Number of pages5
ISSN0361-8609
DOIs
Publication statusPublished - Aug 2026

Keywords

  • bispecific antibodies
  • cytokine release syndrome
  • IgRT
  • immunoglobulin
  • immunoglobulin replacement therapy
  • infections
  • multiple myeloma
  • prophylactic tocilizumab

Cite this